{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:32:07Z","timestamp":1766050327410,"version":"3.37.3"},"reference-count":15,"publisher":"BMJ","issue":"e3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2023,4,4]]},"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Alpha-2 agonists have analgesic and sedative properties that can prove interesting in palliative care. The main objective of this study was to describe the use of clonidine and dexmedetomidine in palliative care units (PCU). The secondary objective was to identify physicians\u2019 perspectives and attitudes toward alpha-2-agonists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>International multicentric qualitative survey of prescribing characteristics and attitudes towards alpha-2 agonist. All 159 PCUs in France, Belgium and French-speaking Switzerland were contacted, and 142 physicians answered the questionnaire (31% participation).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>20% of the practitioners surveyed prescribe these molecules are mainly for analgesic and sedative indications. There was considerable heterogeneity in the modalities and dosages of administration. The use of clonidine is more frequent and common in Belgium, while dexmedetomidine is only used in France. There is a high level of satisfaction among practitioners who use these molecules, with the desire of the majority of respondents to obtain additional studies and information on alpha-2-agonists.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Alpha-2 agonists are little known and little prescribed by French-speaking palliative care physicians but are of interest because of their potential in this field. Phase 3 studies could justify the use of these molecules in palliative situations and would contribute to harmonising professional practices.<\/jats:p><\/jats:sec>","DOI":"10.1136\/spcare-2023-004193","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T17:20:13Z","timestamp":1681924813000},"page":"e876-e880","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Dexmedetomidine and clonidine in palliative medicine: multicentric qualitative evaluation"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-5219","authenticated-orcid":false,"given":"Chlo\u00e9","family":"Prod'homme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Werbrouck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magali","family":"Pierrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helene","family":"Lesaffre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Pasqualini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Licia","family":"Touzet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"2024121022580592000_13.e3.e876.1","doi-asserted-by":"publisher","DOI":"10.1177\/1049909110389804"},{"key":"2024121022580592000_13.e3.e876.2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/ALN.0000000000001214","article-title":"From bench to bedside and back again: A personal journey with dexmedetomidine","volume":"125","author":"Maze","year":"2016","journal-title":"Anesthesiology"},{"key":"2024121022580592000_13.e3.e876.3","article-title":"Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients","volume":"1","author":"Chen","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2024121022580592000_13.e3.e876.4","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.21037\/apm-21-1989","article-title":"Dexmedetomidine: a magic bullet on its way into palliative care-a narrative review and practice recommendations","volume":"11","author":"Gaertner","year":"2022","journal-title":"Ann Palliat Med"},{"key":"2024121022580592000_13.e3.e876.5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/0269216321994440","article-title":"Dexmedetomidine for hyperactive delirium at the end of life: an open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit","volume":"35","author":"Thomas","year":"2021","journal-title":"Palliat Med"},{"key":"2024121022580592000_13.e3.e876.6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jclinane.2017.02.003","article-title":"What is the place of clonidine in anesthesia? Systematic review and meta-analyses of randomized controlled trials","volume":"38","author":"Sanchez Munoz","year":"2017","journal-title":"J Clin Anesth"},{"key":"2024121022580592000_13.e3.e876.7","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/pm\/pnv102","article-title":"Pain modulation and autonomic function: the effect of clonidine","volume":"17","author":"Nahman-Averbuch","year":"2016","journal-title":"Pain Med"},{"key":"2024121022580592000_13.e3.e876.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(01)00250-0"},{"key":"2024121022580592000_13.e3.e876.9","doi-asserted-by":"publisher","DOI":"10.1136\/spcare-2022-003651"},{"key":"2024121022580592000_13.e3.e876.10","doi-asserted-by":"publisher","DOI":"10.3109\/15360288.2010.518227"},{"key":"2024121022580592000_13.e3.e876.11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/0269216319896955","article-title":"Practice review: evidence-based and effective management of pain in patients with advanced cancer","volume":"34","author":"Chapman","year":"2020","journal-title":"Palliat Med"},{"key":"2024121022580592000_13.e3.e876.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-008-0441-1"},{"key":"2024121022580592000_13.e3.e876.13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.328.7451.1312"},{"key":"2024121022580592000_13.e3.e876.14","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311417036"},{"key":"2024121022580592000_13.e3.e876.15","unstructured":"University Hospital, Limoges . Prospective study of the use of dexmedetomidine in light to moderate sedation in the patient in the palliative situation of a Sars-cov-2 \/ COVID-19 infection [internet]. clinicaltrials.gov; report no.: NCT04350086 . 2020. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04350086"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2023-004193","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T07:15:08Z","timestamp":1733901308000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2023-004193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":15,"journal-issue":{"issue":"e3","published-online":{"date-parts":[[2024,1,8]]},"published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1136\/spcare-2023-004193"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2023-004193","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"type":"print","value":"2045-435X"},{"type":"electronic","value":"2045-4368"}],"subject":[],"published":{"date-parts":[[2023,4,19]]}}}